Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A latent class analysis of clinical complexity: Secondary analysis of the collaboration leading to addiction treatment and recovery from other stresses (CLARO) randomized trial.

Addiction (Abingdon, England)·2026
Same author

Cancer Diagnostic Delay Rates Associated With a Population-Based Screening Trial Evaluating a Cell-Free DNA Multicancer Early Detection Test.

JAMA·2026
Same author

Q-Learning with clustered-SMART (cSMART) data: examining moderators in the construction of clustered adaptive interventions.

Biometrics·2026
Same author

The impact of collaborative care on perceptions of treatment across racial and ethnic groups.

Frontiers in health services·2026
Same author

Workforce and Staffing at 988 Suicide & Crisis Lifeline Centers.

JAMA network open·2026
Same author

Stimulant use and increased severity of opioid use disorder and mental illness in patients with co-occurring disorders.

Journal of substance use and addiction treatment·2026
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
Same journal

Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions.

Statistics in medicine·2026
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: May 13, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

A tutorial on propensity score estimation for multiple treatments using generalized boosted models.

Daniel F McCaffrey1, Beth Ann Griffin, Daniel Almirall

  • 1The RAND Corporation, 4570 Fifth Avenue, Pittsburgh, PA 15213, USA. danielm@rand.org

Statistics in Medicine
|March 20, 2013
PubMed
Summary
This summary is machine-generated.

This study provides guidance for using propensity scores with multiple treatments, proposing generalized boosted models (GBM) for accurate causal effect estimation in observational research.

Keywords:
GBMcausal effectscausal modelinginverse probability of treatment weightingtwang

Related Experiment Videos

Last Updated: May 13, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Area of Science:

  • Epidemiology
  • Biostatistics
  • Causal Inference

Background:

  • Propensity scores are widely used in observational studies to control for pretreatment imbalances.
  • Inverse probability of treatment weighting (IPTW) with propensity scores from boosted models is effective for two treatments.
  • Existing guidance and tools are limited for studies involving three or more treatment groups.

Purpose of the Study:

  • To offer step-by-step guidance for implementing propensity score weighting in multiple-treatment scenarios.
  • To propose generalized boosted models (GBM) for estimating propensity scores in complex treatment settings.
  • To define relevant causal quantities and derive weighted estimators for multi-treatment studies.

Main Methods:

  • Utilizing generalized boosted models (GBM) for propensity score estimation.
  • Implementing inverse probability of treatment weighting (IPTW) for causal effect estimation.
  • Developing tools for assessing covariate balance and treatment group overlap in multi-treatment studies.

Main Results:

  • The paper defines causal quantities and derives weighted estimators for multiple treatments.
  • A detailed plan is presented for using GBM to estimate propensity scores, weights, and causal effects.
  • Methods are demonstrated through a case study on adolescent substance abuse treatment programs.

Conclusions:

  • This work extends propensity score methods to handle multiple treatment groups effectively.
  • Generalized boosted models (GBM) are proposed as a robust tool for propensity score estimation in complex settings.
  • The provided guidance and tools facilitate rigorous causal inference in observational studies with multiple treatments.